C34.90, Malignant neoplasm of unspecified part of unspecified bronchus or lungICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L38284, MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
J15
CGS-J15-L40225, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
J15
CGS-J15-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J15
CGS-J15-L37903, MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
J15
CGS-J15-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J15
CGS-J15-L36021, MolDX: Molecular Diagnostic Tests (MDT)
J15
CGS-J15-L38067, MolDX: Next-Generation Sequencing for Solid Tumors
J15
CGS-J18-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J18
CGS-J18-L37903, MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
J18
CGS-J18-L36021, MolDX: Molecular Diagnostic Tests (MDT)
J18
CGS-J18-L40225, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
J18
CGS-J18-L38284, MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
J18
CGS-J18-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J18
CGS-J18-L38067, MolDX: Next-Generation Sequencing for Solid Tumors
J18
WPS-J5-L38158, MolDX: Next-Generation Sequencing for Solid Tumors
J5
WPS-J5-L37921, MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
J5
WPS-J5-L38168, MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J5
WPS-J5-L36807, MolDX: Molecular Diagnostic Tests (MDT)
J5
WPS-J5-L38443, MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
J5
WPS-J5-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.